## Current ART Initiation Guidelines in India **Key Point:** India adopted the "Treat All" strategy in 2017, which was reinforced in the 2023 NACO guidelines. This means ART is initiated in all HIV-positive individuals regardless of CD4+ count or WHO clinical stage. **High-Yield:** The shift from CD4+-based initiation thresholds (historically <200, then <350, then <500) to universal treatment reflects global evidence that: - Early ART reduces viral load and transmission risk (U=U: Undetectable = Untransmittable) - Immune reconstitution occurs faster - Mortality and morbidity are significantly reduced - Population-level viral suppression is achieved **Clinical Pearl:** This strategy is particularly important in India's high-burden HIV epidemic to maximize treatment coverage and reduce onward transmission in key populations (MSM, sex workers, PWID). **Mnemonic:** **TREAT ALL** = **T**imely **R**ecognition **E**arly **A**RT **T**herapy **A**chieving **L**ong-term **L**ife expectancy. ## Why This Matters - Eliminates delays in treatment initiation - Reduces stigma (no need to wait for CD4 count) - Improves linkage to care and retention - Aligns with WHO 90-90-90 and 95-95-95 targets
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.